Clave |
1944 |
Nombre del Convenio o Proyecto Patrocinado |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a shar |
Fecha de Inicio |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a |
Fecha de Culminación (tentativo) |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a |
Objetivos del Proyecto |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a share, inthe second quarter, compared with C$312 million, or 48 cents ashare, a year before.
|
Personal del área que Participa en el Proyecto Patrocinado |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a share, inthe second quarter, compared with C$312 million, or 48 cents ashare, a year before.
|
Instituciones Participantes (en su caso) |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a share, inthe second quarter, compared with C$312 million, or 48 cents ashare, a year before.
|
Justificacion |
I like it a lot https://www.singingriverretirement.com/stmap_64kncqzz.html?bicalutamide.levitra.satibo.vantin ivermectin approved by fda The Vancouver-based company said it had adjusted earnings ofC$354 million ($340 million), or 54 Canadian cents a share, inthe second quarter, compared with C$312 million, or 48 cents ashare, a year before.
|
Numero Economico |
0 |
Fecha_registro |
2022-06-27 18:56:52 |